- Home
- Europe Q Pcr Reagents Market
Europe Q-PCR Reagents Market - Industry Trends And Forecast To 2029
- Published Date: July, 2022 | Report ID: CLS-18 | No of pages: 200 | Format:
Europe q-PCR reagents market is projected to register a substantial CAGR of 5.5% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2019, the base year of calculation is 2021 and the forecast period is 2022 to 2029.
Market Segmentation:
Europe Q-PCR Reagents Market, By Detection Type (Dye -Based Reagents and Probe -Based Reagents), Assay Type (Qpcr Singleplex Test/Assay and Qpcr Multiplex Test/Assay), Plexity (Dye -Based Reagents and Probe -Based Reagents), Packaging Type (Kits and Master Mixes), Technology (Gene Expression, Gene Typing, MIRNA Analysis, Pre-Amplification and Virus Detection), Application (Diagnostics, Research and Forensic), End User (Hospital & Diagnostic Centers, Forensic Laboratories, Research & Academic Institute, Clinical Research Organization, and Others), Distribution Channel (Direct Tender, Third Party Distributors, and Others), Country (Germany, France, U.K., Hungary, Lithuania, Austria, Ireland, Norway, Poland, Italy, Spain, Russia, U.K., Italy, Netherland, Switzerland, Turkey, Belgium, Rest of Europe) Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the Europe q-PCR reagents market are:
• Increasing healthcare expenditure
• Rising geriatric population
Market Players:
The key market players for Europe q-PCR reagents market are listed below:
• Bio-Rad Laboratories, Inc.
• Agilent Technologies, Inc
• Norgen Biotek Corp
• Takara Holdings Inc.
• Enzo Biochem Inc
• Qiagen
• PCR Biosystems
• Tonbo Biosciences
• Quantabio
• Merck KgaA
• Kaneka Eurogentec S.A
TABLE OF CONTENT
| 1 INTRODUCTION 1.1 OBJECTIVES OF THE STUDY 1.2 MARKET DEFINITION 1.3 OVERVIEW OF EUROPE Q-PCR REAGENTS MARKET 1.4 LIMITATIONS 1.5 MARKETS COVERED 2 MARKET SEGMENTATION 2.1 MARKETS COVERED 2.2 GEOGRAPHICAL SCOPE 2.3 YEARS CONSIDERED FOR THE STUDY 2.4 CURRENCY AND PRICING 2.5 DBMR TRIPOD DATA VALIDATION MODEL 2.6 MULTIVARIATE MODELLING 2.7 DETECTION TYPE LIFELINE CURVE 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 2.9 DBMR MARKET POSITION GRID 2.10 MARKET APPLICATION COVERAGE GRID 2.11 VENDOR SHARE ANALYSIS 2.12 SECONDARY SOURCES 2.13 ASSUMPTIONS 3 EXECUTIVE SUMMARY 4 PREMIUM INSIGHTS 5 INDUSTRIAL INSIGHTS 5.1 PESTEL ANALYSIS 5.2 PORTER'S FIVE FORCES MODEL 6 EUROPE Q-PCR REAGENTS MARKET: REGULATIONS 6.1 REGULATION IN U.S 6.2 REGULATION IN EUROPE 6.3 REGULATION IN SINGAPORE 6.4 REGULATION IN AUSTRALIA 7 MARKET OVERVIEW 7.1 DRIVERS 7.1.1 INCREASE IN CHRONIC DISEASES AND COMMUNICABLE DISEASES 7.1.2 INCREASE IN GERIATRIC POPULATION 7.1.3 INCREASE IN EARLY DIAGNOSIS RATE 7.1.4 INCREASE IN ADVANCED TECHNOLOGY 7.2 RESTRAINTS 7.2.1 STRINGENT RULES & REGULATIONS 7.2.2 HIGH COST OF PRODUCT 7.2.3 NON-AVAILABILITY OF RELEVANT AND APPROPRIATE KITS 7.2.4 ADVANCEMENT IN FIELD OF GENOMICS 7.3 OPPORTUNITIES 7.3.1 RISE IN GOVERNMENT FUNDING FOR HEALTHCARE 7.3.2 RISE IN HEALTHCARE EXPENDITURE 7.4 CHALLENGES 7.4.1 LACK OF SKILLED WORKFORCE 7.4.2 OPERATIONAL BARRIERS FACED IN CONDUCTING DIAGNOSTIC TESTS 8 IMPACT OF COVID-19 ON THE EUROPE Q-PCR REAGENTS MARKET 8.1 IMPACT ON PRICE 8.2 IMPACT ON DEMAND 8.3 IMPACT ON SUPPLY CHAIN 8.4 STRATEGIC DECISIONS BY MANUFACTURERS 8.5 CONCLUSION 9 EUROPE Q-PCR REAGENTS MARKET, BY DETECTION TYPE 9.1 OVERVIEW 9.2 DYE-BASED REAGENTS 9.2.1 MASTER MIX 9.2.2 PRIMERS 9.2.3 DNA TEMPLATE 9.3 PROBE-BASED REAGENTS 9.3.1 MASTER MIX 9.3.2 PRIMERS 9.3.3 DNA TEMPLATE 10 EUROPE Q-PCR REAGENTS MARKET, BY ASSAY TYPE 10.1 OVERVIEW 10.2 QPCR SINGLEPLEX TEST/ASSAY 10.3 QPCR MULTIPLEX TEST/ASSAY 11 EUROPE Q-PCR REAGENTS MARKET, BY PLEXITY 11.1 OVERVIEW 11.2 DYE-BASED REAGENTS 11.2.1 SINGLEPLEX 11.2.2 MULTIPLEX 11.3 PROBE-BASED REAGENTS 11.3.1 SINGLEPLEX 11.3.2 MULTIPLEX 12 EUROPE Q-PCR REAGENTS MARKET, BY PACKAGING TYPE 12.1 OVERVIEW 12.2 KITS 12.3 MASTER MIXERS 13 EUROPE Q-PCR REAGENTS MARKET, BY TECHNOLOGY 13.1 OVERVIEW 13.2 GENE EXPRESSION 13.3 GENE TYPING 13.4 MIRNA ANALYSIS 13.5 PRE-AMPLIFICATION 13.6 VIRUS DETECTION 14 EUROPE Q-PCR REAGENTS MARKET, BY APPLICATION 14.1 OVERVIEW 14.2 RESEARCH 14.3 DIAGNOSTICS 14.4 FORENSIC 15 EUROPE Q-PCR REAGENTS MARKET, BY END USER 15.1 OVERVIEW 15.2 RESEARCH & ACADEMIC INSTITUTE 15.3 HOSPITAL AND DIAGNOSTIC CENTERS 15.4 CLINICAL RESEARCH ORGANIZATION 15.5 FORENSIC LABORATORIES 15.6 OTHERS 16 EUROPE Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL 16.1 OVERVIEW 16.2 DIRECT TENDER 16.3 THIRD PARTY DISTRIBUTORS 16.4 OTHERS 17 EUROPE Q-PCR REAGENTS MARKET, BY REGION 17.1 EUROPE 17.1.1 GERMANY 17.1.2 U.K. 17.1.3 FRANCE 17.1.4 ITALY 17.1.5 SPAIN 17.1.6 NETHERLANDS 17.1.7 SWITZERLAND 17.1.8 BELGIUM 17.1.9 POLAND 17.1.10 AUSTRIA 17.1.11 IRELAND 17.1.12 HUNGARY 17.1.13 NORWAY 17.1.14 RUSSIA 17.1.15 TURKEY 17.1.16 LITHUANIA 17.1.17 REST OF EUROPE 18 EUROPE Q-PCR REAGENTS MARKET: COMPANY LANDSCAPE 18.1 COMPANY SHARE ANALYSIS: EUROPE 19 EUROPE Q-PCR REAGENTS MARKET: SWOT ANALYSIS 20 COMPANY PROFILE 20.1 F. HOFFMANN-LA ROCHE LTD 20.1.1 COMPANY SNAPSHOT 20.1.2 REVENUE ANALYSIS 20.1.3 PRODUCT PORTFOLIO 20.1.4 RECENT DEVELOPMENT 20.2 MERCK KGAA 20.2.1 COMPANY SNAPSHOT 20.2.2 REVENUE ANALYSIS 20.2.3 PRODUCT PORTFOLIO 20.2.4 RECENT DEVELOPMENTS 20.2.4.1 PARTNERSHIP 20.2.4.2 NEW LABORATORY FACILITY 20.2.4.3 NEW DISTRIBUTION CENTER 20.3 THERMO FISHER SCIENTIFIC INC 20.3.1 COMPANY SNAPSHOT 20.3.2 REVENUE ANALYSIS 20.3.3 PRODUCT PORTFOLIO 20.3.4 RECENT DEVELOPMENTS 20.3.4.1 ACQUISITION 20.3.4.2 PRODUCT LAUNCH 20.4 AGILENT TECHNOLOGIES, INC 20.4.1 COMPANY SNAPSHOT 20.4.2 REVENUE ANALYSIS 20.4.3 PRODUCT PORTFOLIO 20.4.4 RECENT DEVELOPMENTS 20.4.4.1 DISTRIBUTION AGREEMENT 20.4.4.2 PRODUCT LAUNCH 20.5 SEEGENE INC. 20.5.1 COMPANY SNAPSHOT 20.5.2 PRODUCT PORTFOLIO 20.5.3 RECENT DEVELOPMENT 20.6 BIONEER CORPORATION 20.6.1 COMPANY SNAPSHOT 20.6.2 PRODUCT PORTFOLIO 20.6.3 RECENT DEVELOPMENT 20.7 BIO-RAD LABORATORIES, INC. 20.7.1 COMPANY SNAPSHOT 20.7.2 REVENUE ANALYSIS 20.7.3 PRODUCT PORTFOLIO 20.7.4 RECENT DEVELOPMENTS 20.7.4.1 PARTNERSHIP 20.7.4.2 AWARD 20.8 BIOTIUM 20.8.1 COMPANY SNAPSHOT 20.8.2 PRODUCT PORTFOLIO 20.8.3 RECENT DEVELOPMENTS 20.9 EMPIRICAL BIOSCIENCE, INC. 20.9.1 COMPANY SNAPSHOT 20.9.2 PRODUCT PORTFOLIO 20.9.3 RECENT DEVELOPMENTS 20.9.3.1 EUA AUTHORISATION 20.9.3.2 ISO CERTIFICATION 20.9.3.3 PRODUCT LAUNCH 20.10 ENZO BIOCHEM INC 20.10.1 COMPANY SNAPSHOT 20.10.2 REVENUE ANALYSIS 20.10.3 PRODUCT PORTFOLIO 20.10.4 RECENT DEVELOPMENT 20.11 GENEDIREX, INC 20.11.1 COMPANY SNAPSHOT 20.11.2 PRODUCT PORTFOLIO 20.11.3 RECENT DEVELOPMENT 20.12 KANEKA EUROGENTEC S.A 20.12.1 COMPANY SNAPSHOT 20.12.2 REVENUE ANALYSIS 20.12.3 PRODUCT PORTFOLIO 20.12.4 RECENT DEVELOPMENT 20.13 MIRXES PTE LTD 20.13.1 COMPANY SNAPSHOT 20.13.2 PRODUCT PORTFOLIO 20.13.3 RECENT DEVELOPMENT 20.14 NORGEN BIOTEK CORP 20.14.1 COMPANY SNAPSHOT 20.14.2 PRODUCT PORTFOLIO 20.14.3 RECENT DEVELOPMENT 20.15 NEW ENGLAND BIOLABS 20.15.1 COMPANY SNAPSHOT 20.15.2 PRODUCT PORTFOLIO 20.15.3 RECENT DEVELOPMENTS 20.15.3.1 AQUISITION 20.15.3.2 PRODUCT LAUNCH 20.15.3.3 SUBSIDIARY 20.16 PCR BIOSYSTEMS 20.16.1 COMPANY SNAPSHOT 20.16.2 PRODUCT PORTFOLIO 20.16.3 RECENT DEVELOPMENT 20.17 PROMEGA CORPORATION 20.17.1 COMPANY SNAPSHOT 20.17.2 PRODUCT PORTFOLIO 20.17.3 RECENT DEVELOPMENT 20.18 QIAGEN 20.18.1 COMPANY SNAPSHOT 20.18.2 REVENUE ANALYSIS 20.18.3 PRODUCT PORTFOLIO 20.18.4 RECENT DEVELOPMENTS 20.18.4.1 NEW FACILITY 20.18.4.2 ACQUISITION 20.19 QUANTABIO 20.19.1 COMPANY SNAPSHOT 20.19.2 PRODUCT PORTFOLIO 20.19.3 RECENT DEVELOPMENTS 20.19.3.1 CONFERENCE 20.19.3.2 PRODUCT LAUNCH 20.20 SINO BIOLOGICAL INC. 20.20.1 COMPANY SNAPSHOT 20.20.2 PRODUCT PORTFOLIO 20.20.3 RECENT DEVELOPMENT 20.21 SOLIS BIODYNE 20.21.1 COMPANY SNAPSHOT 20.21.2 PRODUCT PORTFOLIO 20.21.3 RECENT DEVELOPMENT 20.22 TAKARA HOLDINGS INC 20.22.1 COMPANY SNAPSHOT 20.22.2 REVENUE ANALYSIS 20.22.3 PRODUCT PORTFOLIO 20.22.4 RECENT DEVELOPMENTS 20.22.4.1 MANUFACTURING UNIT 20.22.4.2 ISO CERTIFICATION 20.23 TONBO BIOSCIENCES 20.23.1 COMPANY SNAPSHOT 20.23.2 PRODUCT PORTFOLIO 20.23.3 RECENT DEVELOPMENT 20.24 TRANSGENE BIOTEK LIMITED 20.24.1 COMPANY SNAPSHOT 20.24.2 REVENUE ANALYSIS 20.24.3 PRODUCT PORTFOLIO 20.24.4 RECENT DEVELOPMENT 20.25 YOUSEQ LTD 20.25.1 COMPANY SNAPSHOT 20.25.2 PRODUCT PORTFOLIO 20.25.3 RECENT DEVELOPMENT 21 QUESTIONNAIRE 22 RELATED REPORTS |
Segmentation
Europe Q-PCR Reagents Market, By Detection Type (Dye -Based Reagents and Probe -Based Reagents), Assay Type (Qpcr Singleplex Test/Assay and Qpcr Multiplex Test/Assay), Plexity (Dye -Based Reagents and Probe -Based Reagents), Packaging Type (Kits and Master Mixes), Technology (Gene Expression, Gene Typing, MIRNA Analysis, Pre-Amplification and Virus Detection), Application (Diagnostics, Research and Forensic), End User (Hospital & Diagnostic Centers, Forensic Laboratories, Research & Academic Institute, Clinical Research Organization, and Others), Distribution Channel (Direct Tender, Third Party Distributors, and Others), Country (Germany, France, U.K., Hungary, Lithuania, Austria, Ireland, Norway, Poland, Italy, Spain, Russia, U.K., Netherland, Switzerland, Turkey, Belgium, Rest of Europe) Industry Trends and Forecast to 2029
Market Definition:
The q-PCR reagents help in the determination of absolute or relative amounts of a known sequence in a sample and are used in different applications such as forensic, research, and diagnostics.
The demand for q-PCR reagents has been increased in both developed well as in developing countries and the reason behind this is the increasing geriatric population and product launch. The q-PCR reagents market is growing due to the introduction of innovative products, increase in technological products, and rising disposable income. The market will grow in the forecasted period due to exploration of emerging markets, strategic initiatives by market players, increasing healthcare expenditure.
Market Segmentation:
Europe q-PCR reagents market is categorized into seven notable segment which is detection type, assay type, plexity, packaging type, application, technology, end user, and distribution channel.
• On the basis of detection type, the Europe Q-PCR reagents market is segmented into dye -based reagents and probe -based reagents
• On the basis of assay type, the Europe Q-PCR reagents market is segmented into qPCR singleplex test/assay and qPCR multiplex test/assay
• On the basis of plexity, the Europe Q-PCR reagents market is segmented into dye -based reagents and probe -based reagents
• On the basis of packaging type, the Europe Q-PCR reagents market is segmented into kits and master mixes
• On the basis of technology, the Europe Q-PCR reagents market is segmented into gene expression, gene typing, MIRNA analysis, pre-amplification and virus detection
• On the basis of application, the Europe Q-PCR reagents market is segmented into diagnostics, research and forensic
• On the basis of end user, the Europe Q-PCR reagents market is segmented into hospital & diagnostic centers, forensic laboratories, research & academic institute, clinical research organization, pharmaceutical and biopharmaceutical companies, and others
• On the basis of distribution channel, the Europe Q-PCR reagents market is segmented into direct tender third party distributors, and others
Market Players
The key market players for Europe q-PCR reagents market are listed below:
• Bio-Rad Laboratories, Inc.
• Agilent Technologies, Inc
• Biotium,
• MiRXES Pte Ltd
• GeneDireX, Inc
• F. Hoffmann-La Roche Ltd
• Norgen Biotek Corp
• Takara Holdings Inc.
• Enzo Biochem Inc
• Qiagen
• PCR Biosystems
• Tonbo Biosciences
• Quantabio
• Merck KgaA
Methodology
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
© 2025 Cognate Lifesciences. All Rights Reserved.